Skip to main content

ANIP Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

ANI Pharmaceuticals Inc. News

3 Biotech Stocks I Love for March (Celgene Is One of Them)

These biotech names are all great buys on dips. Notably Celgene, which is fresh off a terrible trading session.

5 stocks poised for major breakouts

These stocks are within range of triggering breakout trades. Here's how to trade them from here.

ANI Pharmaceuticals' varied offerings, strategic acquisitions make it a good play for investors

The Baudette, Minn.-based company has 79 products generating about $4 billion in sales and a number of other promising therapies in its pipeline.

Strong On High Relative Volume: ANI Pharmaceuticals (ANIP)

Trade-Ideas LLC identified ANI Pharmaceuticals (ANIP) as a strong on high relative volume candidate

Perilous Reversal Watch: ANI Pharmaceuticals (ANIP)

Trade-Ideas LLC identified ANI Pharmaceuticals (ANIP) as a "perilous reversal" (up big yesterday but down big today) candidate

Breaking News

Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll

Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.

Summers, Others Cite Growing Chance of Recession

GDP shrank an annualized 1.6% in the first quarter, and some experts anticipate another drop in the second quarter.

Coinbase Faces A New Scandal

The platform denies selling proprietary customer data and announces it is expanding into several European countries.